Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001869011 | SCV002226394 | pathogenic | not provided | 2024-10-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg112*) in the CIB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CIB1 are known to be pathogenic (PMID: 30068544). This variant is present in population databases (rs143773090, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with epidermodysplasia verruciformis (PMID: 30068544). This variant is also known as c.214C>T (p.Arg72*). ClinVar contains an entry for this variant (Variation ID: 599257). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000735848 | SCV000863999 | risk factor | Epidermodysplasia verruciformis, susceptibility to, 3 | 2019-02-01 | no assertion criteria provided | literature only |